Pharmacokinetics of mycophenolate mofetil in renal graft recipients treated with sirolimus.

被引：0
|
作者：
Buchler, M
Beneton, M
Lemeur, Y
Westeel, PF
Heng, AE
Idier, I
Lebranchu, Y
Paintaud, G
机构：
[1] CHU Bretonneau, F-37044 Tours, France
[2] CHU Limoges, Limoges, France
[3] CHU Amiens, Amiens, France
[4] CHU Clermont Ferrand, Clermont Ferrand, France
[5] Wyeth Pharma, Dept Med, Paris, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
352
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [1] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
    Kreis, H
    Cisterne, JM
    Land, W
    Wramner, L
    Squifflet, JP
    Abramowicz, D
    Campistol, JM
    Morales, JM
    Grinyo, JM
    Mourad, G
    Berthoux, FC
    Brattström, C
    Lebranchu, Y
    Vialtel, P
    [J]. TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260
  • [2] Pharmacokinetics of mycophenolate mofetil and sirolimus in children
    Filler, Guido
    Bendrick-Peart, Jamie
    Christians, Uwe
    [J]. THERAPEUTIC DRUG MONITORING, 2008, 30 (02) : 138 - 142
  • [3] Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis
    Morgera, S
    Budde, K
    Lampe, D
    Ahnert, V
    Fritsche, L
    Kuchinke, S
    Neumayer, HH
    [J]. TRANSPLANT INTERNATIONAL, 1998, 11 (01) : 53 - 57
  • [4] Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysis
    Morgera, S
    Neumayer, HH
    Fritsche, L
    Kuchinke, S
    Lampe, D
    Ahnert, V
    Bauer, S
    Mai, I
    Budde, K
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (03) : 159 - 163
  • [5] Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
    ter Meulen, CG
    Gregoor, PJHS
    Weimar, W
    Hilbrands, LB
    [J]. TRANSPLANT INTERNATIONAL, 2001, 14 (02) : 99 - 102
  • [6] Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
    van Gelder, T
    ter Meulen, CG
    Hené, R
    Weimar, W
    Hoitsma, A
    [J]. TRANSPLANTATION, 2003, 75 (06) : 788 - 791
  • [7] CLINICAL STUDY OF THE CONVERSION TREATMENT WITH SIROLIMUS AND MYCOPHENOLATE MOFETIL IN THE RENAL TRANSPLANT RECIPIENTS
    Ji, Shu-ming
    Li, Lei-shi
    Wen, Ji Qiu
    Sha, Guo-zhu
    Cheng, Dong-rui
    Sun, Qi-quan
    Chen, Jin-song
    Liu, Zhi-hong
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 109 - 109
  • [8] Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients
    Pescovitz, MD
    Govani, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S16 - S21
  • [9] Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss
    Boratynska, M
    Magott, M
    Klinger, M
    Smolska, D
    Rychlewska, B
    Myszka, K
    Szepietowski, T
    Szyber, P
    Patrzalek, D
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) : 553 - 555
  • [10] Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil
    François, M
    Büchler, M
    Halimi, JM
    Al-Najjar, A
    Valentin, JF
    Thibault, G
    Lebranchu, Y
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2781 - 2782
12345